Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00104767 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: celecoxib

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]